It also was found to reduce the frequency of various cancers by inhibiting the mechanistic target of rapamycin (mTOR) via AMPK activation in pre-neoplastic cells, thereby hindering cell proliferation and promoting apoptosis (Chan, 2016; Demb et al., 2019; Kim et al., 2020). Here, MTOR is linked to cancer.